Presentation

Continuing versus Suspending Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers:Impact on Adverse Outcomes in Hospitalized Patients with Severe Acute Respiratory Distress Syndrome Coronavirus 2 (SARS-CoV-2

Presenter: Renato D. Lopes

August 30, 2021

REGISTER for free or LOG IN to view this content

Continuing versus Suspending Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers:Impact on Adverse Outcomes in Hospitalized Patients with Severe Acute Respiratory Distress Syndrome Coronavirus 2 (SARS-CoV-2

Presentation

ESC 2021

COVID-19

SARS-CoV-2

angiotensin receptor blocker

Up Next

Presentation

Implantable Loop Recorder to Detect Atrial Fibrillation and Prevent Stroke (The LOOP Study): A Randomised Controlled Trial

Presenter: Jesper Hastrup Svendsen

August 31, 2021

More slides +

Presentation

One-month Dual Antiplatelet Therapy Followed by Clopidogrel Monotherapy in Acute Coronary Syndrome:

Presenter: Hirotoshi Watanabe

August 31, 2021

Presentation

Primary Outcomes of the Amplatzer Amulet IDE Randomized Controlled Trial

Presenter: Dhanunjaya Lakkireddy

August 31, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.